
Royalty Pharma plc
SHS CLASS A
RPRX institutional ownership changes in Q2 2026: 163 institutions opened or added positions, 89 trimmed or exited. RPRX (Royalty Pharma plc) is held by 249 institutional investors as of Q2 2026. Top institutional shareholders: Morgan Stanley ($2.4B), Capital International Investors ($2B), BlackRock, Inc. ($1.6B). Institutions were buying, on balance.
Who's Trading
Latest move
Source dates: Price Nov 6, 2026 · Insiders Nov 6, 2026 · Activists Nov 5, 2026 · Congress none
Top Holders
Showing 1-20 of 259
Continue exploring
Other Healthcare stocks held by institutions
Questions investors ask about RPRX
Who owns RPRX?
249 institutional investors held RPRX on June 30, 2026, led by Morgan Stanley ($2.4B), Capital International Investors ($2B) and BlackRock, Inc. ($1.6B).
How many hedge funds hold RPRX?
249 institutional investors reported RPRX in their 13F filings for the quarter ended June 30, 2026, $18.1B in all. 14 of them are rated Elite.
Are institutions buying or selling RPRX?
Buying, on balance. In Q2 2026, 163 institutions opened or added to positions in RPRX and 89 institutions trimmed or exited.
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer